Jaffer U, Weedon K, Cameron A E P
Directorate of Surgery, Ipswich Hospital NHS Trust, Ipswich, UK.
Br J Surg. 2007 Sep;94(9):1108-12. doi: 10.1002/bjs.5792.
Endoscopic thoracic sympathectomy (ETS) is an effective treatment for palmar hyperhidrosis and has been extended to craniofacial symptoms such as blushing and facial sweating. Adverse effects, including compensatory sweating, may cause patients to regret surgery. Such adverse events are currently unpredictable. This study investigated whether age, sex or bodyweight influenced the outcome.
A total of 110 patients who had bilateral ETS for palmar hyperhidrosis or facial symptoms (blushing or sweating) were asked to complete a questionnaire before and after surgery regarding physical and emotional symptoms, and overall satisfaction.
Seventy-nine usable questionnaires were obtained. A decrease (an improvement) in physical symptom score was found in all patients; the median (interquartile range) change was - 15 (-9 to - 18) for facial symptoms and - 8 (-6.75 to - 9) for palmar symptoms. Similarly, there was an improvement in emotional symptom score of - 16 (-8 to - 28) for facial symptoms and - 13 (-7.25 to - 18.5) for palmar symptoms. More compensatory sweating was noted in those treated for facial symptoms (P = 0.007). There was no influence of age, sex or body mass index on outcome.
ETS is an effective treatment for palmar and facial symptoms. Side-effects may be worse in patients treated for facial symptoms.
内镜胸交感神经切断术（ETS）是治疗手掌多汗症的有效方法，并且已扩展至治疗诸如脸红和面部出汗等颅面部症状。包括代偿性出汗在内的不良反应可能会使患者对手术感到后悔。目前，此类不良事件无法预测。本研究调查了年龄、性别或体重是否会影响手术结果。
共有110例因手掌多汗症或面部症状（脸红或出汗）接受双侧ETS手术的患者被要求在手术前后完成一份关于身体和情绪症状以及总体满意度的问卷。
获得了79份可用问卷。所有患者的身体症状评分均有所下降（改善）；面部症状的中位数（四分位间距）变化为-15（-9至-18），手掌症状为-8（-6.75至-9）。同样，面部症状的情绪症状评分改善了-16（-8至-28），手掌症状为-13（-7.25至-18.5）。面部症状患者出现更多的代偿性出汗（P = 0.007）。年龄、性别或体重指数对手术结果均无影响。
ETS是治疗手掌和面部症状的有效方法。面部症状患者的副作用可能更严重。
Zotero 插件